Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · IEX Real-Time Price · USD
0.458
+0.008 (1.73%)
At close: Apr 26, 2024, 3:54 PM
0.450
-0.008 (-1.70%)
After-hours: Apr 26, 2024, 7:11 PM EDT

Scinai Immunotherapeutics Cash Flow Statement

Millions ILS. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012
Net Income
-5.8-8.21-1.26-30.82-24.76-9.75-2.59-2.88-2.19-2.27
Upgrade
Depreciation & Amortization
0.560.470.690.460.070.120.180.180.190.2
Upgrade
Share-Based Compensation
1.62.762.671.040.070.150.360.210.10.16
Upgrade
Other Operating Activities
-3.63-2.45-22.587.578.476.64-0.66-0.41-0.240.72
Upgrade
Operating Cash Flow
-7.27-7.43-20.47-21.75-16.14-2.84-2.72-2.9-2.14-1.19
Upgrade
Capital Expenditures
-0.84-0.14-1.69-2.1-6.66-1.27-0.01-0.01-0.01-0.06
Upgrade
Change in Investments
000003.29-2.15000.59
Upgrade
Other Investing Activities
--0.010.060.04-0.11-0.05-0-0.040.04
Upgrade
Investing Cash Flow
-0.84-0.14-1.68-2.03-6.621.91-2.21-0.01-0.050.57
Upgrade
Share Issuance / Repurchase
0.9321.430.0519.83017.4509.5302.61
Upgrade
Debt Issued / Paid
00-0.354.1623.800000
Upgrade
Other Financing Activities
5.84-4.170.05-----0.22-
Upgrade
Financing Cash Flow
6.7821.433.8724.0523.817.4509.53-0.222.61
Upgrade
Exchange Rate Effect
-1.980.580.48-1.230.23-0.81-0.080.120.08-0.07
Upgrade
Net Cash Flow
-3.314.44-17.79-0.961.2715.71-5.016.73-2.331.93
Upgrade
Free Cash Flow
-8.1-7.57-22.16-23.85-22.8-4.11-2.73-2.91-2.15-1.24
Upgrade
Free Cash Flow Per Share
-4.30-5.36-20.00-29.20-34.89-8.18-8.08-11.02-15.81-10.36
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).